FDA (Drugs) recall action 71806
The FDA (Drugs) publishes a recall like this one as 101 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 101 pages.
Lack of Assurance of Sterility; all sterile human compounded drugs within expiry
The agency’s own wording, quoted from the enforcement report.
The unit total adds up the quantities the agency stated for each product. Where a product record gave no figure, or gave a weight rather than a count, it contributes nothing — so the real total is at least this, never less.
The FDA is recalling Estradiol Pellets, 6 mg, compounded by JD & SN Inc. because the agency cannot assure the sterility of the product.
JD & SN Inc. is recalling 92 testosterone pellets because the company cannot ensure they are sterile. The recall covers products distributed nationwide.
The FDA is recalling Estradiol pellets from JD & SN Inc. because the manufacturer cannot ensure the sterile compounded drugs are free of contamination.
JD & SN Inc. is recalling 18-pellet vials of 76 mg Testosterone Pellets because the FDA determined there is a lack of assurance of sterility.
Moses Lake Professional Pharmacy is recalling 355 testosterone pellets because the FDA cannot assure they are sterile. Patients should stop using the product and consult a healthcare provider.
FDA is recalling 64 syringes of compounded chorionic gonadotropin from Moses Lake Professional Pharmacy due to lack of assurance of sterility.
JD & SN Inc. is recalling 26 syringes of Chorionic Gonadotropin/Cyanocobalamin Injectable Solution nationwide due to a lack of assurance of sterility.
JD & SN Inc. is recalling methylcobalamin/hydroxocobalamin syringes because the company cannot ensure the products are sterile.
FDA is recalling Sermorelin/GHRP-6/GHRP-2 injectable solution from Moses Lake Professional Pharmacy due to lack of assurance of sterility.
JD & SN Inc. is recalling a compounded injectable solution because the FDA could not ensure the product remained sterile. Patients should stop using the medication and contact their healthcare provider.
Moses Lake Professional Pharmacy is recalling 22 vials of a compounded injectable solution due to a lack of assurance of sterility.
JD & SN Inc. is recalling specific syringes of Methylcobalamin injectable solution because the agency could not ensure the product remained sterile.
The FDA is recalling compounded progesterone pellets from Moses Lake Professional Pharmacy because the agency cannot ensure the products are sterile.
JD & SN Inc. is recalling specific syringes of Hydroxyprogesterone Caproate Oil because the FDA cannot ensure the sterile compounded drugs are free from contamination.
JD & SN Inc., dba Moses Lake Professional Pharmacy, is recalling Methylcobalamin Injectable Solution because the agency cannot assure the sterility of the compounded drug.
JD & SN Inc. is recalling specific vials of Chorionic Gonadotropin injectable solution because the agency could not ensure the sterile human compounded drugs were sterile.
JD & SN Inc., dba Moses Lake Professional Pharmacy, is recalling 30 mL syringes of 100% sterile ethyl alcohol for injection due to a lack of assurance of sterility.
Moses Lake Professional Pharmacy is recalling 165 syringes of Sermorelin/GHRP-6/GHRP-2 injectable solution due to a lack of assurance of sterility.
Moses Lake Professional Pharmacy is recalling Estradiol 20 mg pellets because the FDA determined there is a lack of assurance of sterility.
JD & SN Inc. is recalling 298 units of compounded testosterone pellets because the FDA cannot ensure the product is sterile.
JD & SN Inc. is recalling 130 mg testosterone pellets because the company cannot ensure they are sterile.
JD & SN Inc., dba Moses Lake Professional Pharmacy, is recalling Estradiol 30 mg pellets because the company cannot ensure the products are sterile.
FDA is recalling specific lots of compounded testosterone pellets because the manufacturer cannot ensure sterility. Patients should contact their healthcare provider.
JD & SN Inc. is recalling 51 testosterone pellets nationwide because the FDA determined there is a lack of assurance of sterility.
JD & SN Inc. is recalling 2 syringes of Papaverine/Phentolamine/Prostaglandin Injectable Solution because the agency cannot assure the sterility of the compounded drug.